Alberto Corsini Selected Research

Alberto Corsini Research Topics

Disease

25	Cardiovascular Diseases (Cardiovascular Disease) 03/2022 - 05/2003
18	Atherosclerosis 05/2022 - 11/2004
13	Inflammation (Inflammations) 02/2022 - 11/2005
11	Muscular Diseases (Myopathy) 01/2018 - 05/2002
7	Type 2 Diabetes Mellitus (MODY) 11/2021 - 02/2009
7	Neoplasms (Cancer) 08/2021 - 11/2005
6	Acute Coronary Syndrome 05/2022 - 01/2007
6	Hypertension (High Blood Pressure) 01/2022 - 05/2003
6	Coronary Disease (Coronary Heart Disease) 06/2020 - 12/2002
6	Dyslipidemias (Dyslipidemia) 03/2020 - 01/2005
5	Drug-Related Side Effects and Adverse Reactions 01/2018 - 08/2011
4	Myalgia 05/2022 - 05/2015
4	Diabetes Mellitus 03/2022 - 06/2014
4	Hypercholesterolemia 10/2021 - 01/2008
4	Obesity 07/2021 - 01/2019
4	Atherosclerotic Plaque (Atheroma) 04/2021 - 07/2009
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 11/2004
3	Stroke (Strokes) 05/2022 - 01/2018
3	Insulin Resistance 01/2022 - 06/2006
3	Heart Failure 01/2022 - 03/2013
3	COVID-19 12/2021 - 09/2020
3	Hypertriglyceridemia 10/2021 - 05/2017
3	Liver Diseases (Liver Disease) 07/2021 - 05/2013
3	Injection Site Reaction 07/2020 - 01/2017
3	Rhabdomyolysis 03/2003 - 05/2002
2	Atrial Fibrillation 05/2022 - 01/2021
2	Venous Thromboembolism 05/2022 - 10/2014
2	Hyperlipidemias (Hyperlipidemia) 02/2022 - 03/2003
2	Non-alcoholic Fatty Liver Disease 01/2022 - 07/2021
2	Alzheimer Disease (Alzheimer's Disease) 06/2019 - 01/2017
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 06/2006
1	Hemorrhage 05/2022
1	Ischemic Stroke 05/2022
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 05/2022
1	Myocardial Infarction 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Tachycardia (Tachyarrhythmias) 01/2022

Drug/Important Bio-Agent (IBA)

32	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2022 - 05/2002
17	CholesterolIBA 02/2022 - 10/2005
16	LipidsIBA 03/2022 - 03/2003
9	oxidized low density lipoproteinIBA 02/2022 - 01/2007
9	Triglycerides (Triacylglycerol)IBA 01/2022 - 11/2005
7	LDL CholesterolIBA 10/2021 - 11/2005
7	Proteins (Proteins, Gene)FDA Link 08/2021 - 02/2012
7	Pharmaceutical PreparationsIBA 07/2021 - 12/2002
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2006
6	Lipoprotein(a)IBA 01/2022 - 07/2020
6	Lipoproteins (Lipoprotein)IBA 01/2022 - 05/2017
5	Transaminases (Aminotransferases)IBA 03/2022 - 06/2004
5	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 07/2011
5	EnzymesIBA 01/2021 - 08/2011
4	Atorvastatin (Lipitor)FDA Link 05/2022 - 05/2002
4	C-Reactive ProteinIBA 07/2021 - 11/2018
4	Proprotein Convertase 9IBA 04/2021 - 02/2016
4	PPAR alphaIBA 09/2019 - 11/2005
4	Fibric Acids (Fibrates)IBA 05/2017 - 03/2003
4	ApolipoproteinsIBA 01/2017 - 11/2007
3	Monoclonal AntibodiesIBA 10/2021 - 06/2020
3	Oxidoreductases (Dehydrogenase)IBA 06/2020 - 12/2002
3	Immunosuppressive Agents (Immunosuppressants)IBA 03/2020 - 03/2003
3	HDL LipoproteinsIBA 01/2019 - 11/2012
3	HDL CholesterolIBA 01/2019 - 11/2005
3	CalponinsIBA 11/2017 - 07/2015
3	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 07/2015 - 05/2002
3	Fluvastatin FDA Link 01/2008 - 01/2004
2	LDL Lipoproteins (beta Lipoproteins)IBA 02/2022 - 01/2019
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022 - 01/2020
2	RNA (Ribonucleic Acid)IBA 01/2022 - 07/2020
2	eicosapentaenoic acid ethyl esterIBA 10/2021 - 01/2020
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2021 - 05/2017
2	LDL Receptors (LDL Receptor)IBA 01/2021 - 07/2015
2	evolocumabIBA 11/2020 - 06/2020
2	Coenzyme A (CoA)IBA 06/2020 - 03/2003
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019 - 06/2013
2	CytokinesIBA 01/2018 - 11/2012
2	pitavastatin (itavastatin)FDA Link 01/2015 - 08/2011
2	Pravastatin (Pravachol)FDA LinkGeneric 01/2015 - 01/2008
2	Bile Acids and Salts (Bile Acids)IBA 05/2013 - 02/2009
2	Indicators and Reagents (Reagents)IBA 05/2010 - 10/2006
2	Simvastatin (Zocor)FDA LinkGeneric 01/2008 - 05/2002
2	Lovastatin (Mevacor)FDA LinkGeneric 01/2008 - 05/2002
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2003 - 05/2002
2	cerivastatin (Kazak)FDA Link 12/2002 - 05/2002
1	apixabanIBA 05/2022
1	AnticoagulantsIBA 05/2022
1	edoxabanIBA 05/2022
1	Warfarin (Coumadin)FDA LinkGeneric 05/2022
1	Dabigatran FDA Link 05/2022
1	RivaroxabanIBA 05/2022
1	Ezetimibe (Zetia)FDA Link 02/2022
1	PolyphenolsIBA 02/2022
1	Angiotensin Receptor AntagonistsIBA 01/2022
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2022
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2022

Therapy/Procedure

17	Therapeutics 11/2021 - 12/2002
4	Polypharmacy 05/2022 - 11/2012
4	Secondary Prevention 06/2020 - 01/2004
2	Kidney Transplantation 03/2020 - 01/2005
2	Drug Therapy (Chemotherapy) 06/2013 - 12/2002
1	Stents 01/2022